INVEST
Fund Two
Investment
A global biopharmaceutical company specializing in the development of new drugs in the field of tumor immunotherapy at the clinical development stage, with a proprietary platform called “Fc-based Biopharmaceutical Design (FBDBTM)” capable of developing various targeted modalities of unique biopharmaceuticals.
With new drug development at its core, the products developed aim to address significant medical needs, including cancer and sepsis.
Actively engage in research on cutting-edge global technologies and innovative applications to continuously strengthen our core competitiveness in the field of innovative immunotherapy.
Engaged in mental health care services, our portfolio includes the FarHugs online platform and self-operated clinics.
Developing new drugs with nanoparticles and nano micelles as the core technology platform.
A veterinarian-founded business focused on animals, covering pet supplies, animal healthcare, grooming, veterinary education, livestock pharmaceuticals, and veterinary IT.
They specialize in thin-film processes, plasma technology, and automation, as well as developing process equipment and thermal modules. Pioneering the SiP EMI Shielding sputtering equipment, we became a key partner in the global smartphone supply chain and now lead the market share.
A company focused on biotechnology research and development and testing services, with innovative biomarker technology at its core. It is dedicated to developing high-value-added products for early disease detection and prevention.
